Molecular Weight:   | 305.2 |
Volume:   | 335.513 |
LogP:   | 3.211 |
LogD:   | 3.525 |
LogS:   | -3.689 |
# Rotatable Bonds:   | 10 |
TPSA:   | 58.56 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 1 |
# Heavy Atoms:   | 4 |
QED Drug-Likeness Score:   | 0.539 |
Synthetic Accessibility Score:   | 2.19 |
Fsp3:   | 0.5 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Rejected |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 1 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.569 |
MDCK Permeability:   | 2.770595165202394e-05 |
Pgp-inhibitor:   | 0.002 |
Pgp-substrate:   | 0.006 |
Human Intestinal Absorption (HIA):   | 0.021 |
20% Bioavailability (F20%):   | 0.886 |
30% Bioavailability (F30%):   | 0.919 |
Blood-Brain-Barrier Penetration (BBB):   | 0.075 |
Plasma Protein Binding (PPB):   | 98.9223861694336% |
Volume Distribution (VD):   | 0.324 |
Pgp-substrate:   | 1.5337800979614258% |
CYP1A2-inhibitor:   | 0.707 |
CYP1A2-substrate:   | 0.847 |
CYP2C19-inhibitor:   | 0.861 |
CYP2C19-substrate:   | 0.805 |
CYP2C9-inhibitor:   | 0.71 |
CYP2C9-substrate:   | 0.942 |
CYP2D6-inhibitor:   | 0.837 |
CYP2D6-substrate:   | 0.882 |
CYP3A4-inhibitor:   | 0.899 |
CYP3A4-substrate:   | 0.242 |
Clearance (CL):   | 6.629 |
Half-life (T1/2):   | 0.904 |
hERG Blockers:   | 0.047 |
Human Hepatotoxicity (H-HT):   | 0.383 |
Drug-inuced Liver Injury (DILI):   | 0.052 |
AMES Toxicity:   | 0.021 |
Rat Oral Acute Toxicity:   | 0.051 |
Maximum Recommended Daily Dose:   | 0.063 |
Skin Sensitization:   | 0.644 |
Carcinogencity:   | 0.03 |
Eye Corrosion:   | 0.004 |
Eye Irritation:   | 0.057 |
Respiratory Toxicity:   | 0.035 |
Natural Product ID:   | NPC255550 |
Common Name*:   | Capsaicin |
IUPAC Name:   | (E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide |
Synonyms:   | Capsaicin; Qutenza; Zacin; Zostrix; Zostrix HP |
Standard InCHIKey:   | YKPUWZUDDOIDPM-SOFGYWHQSA-N |
Standard InCHI:   | InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+ |
SMILES:   | CC(C)/C=C/CCCCC(=NCc1ccc(c(c1)OC)O)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL294199 |
PubChem CID:   |
1548943 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | DOI[10.1246/bcsj.30.618] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[12932131] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[20460582] |
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24813739] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[25172746] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[27466882] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[8910532] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | Flower | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Leaf | n.a. | n.a. | Database[FooDB] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | Leaf | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Pericarp | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Resin, Exudate, Sap | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Root | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | Tissue Culture | n.a. | n.a. | Database[FooDB] |
NPO24552 | Capsicum frutescens | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO23628.1 | Imperata cylindrica var. major | Varieties | Poaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO1320 | Thalictrum ichangense | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | Fruits | n.a. | Database[Phenol-Explorer] | |
NPO2028 | Campsis grandiflora | Species | Bignoniaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO24552 | Capsicum frutescens | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO1320 | Thalictrum ichangense | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO23628.1 | Imperata cylindrica var. major | Varieties | Poaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO24552 | Capsicum frutescens | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO2028 | Campsis grandiflora | Species | Bignoniaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO2028 | Campsis grandiflora | Species | Bignoniaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO16501 | Capsicum annuum | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO29314 | Mangifera indica | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19468 | Madia sativa | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1320 | Thalictrum ichangense | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO2028 | Campsis grandiflora | Species | Bignoniaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18790 | Streptomyces roseofulvus | Species | Streptomycetaceae | Bacteria | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPO16501 | NPC255550 | Other (raw) | Fruit | 900 | 10 | 1790 | mg/100g | Database [DUKE] |
NPO16501 | NPC255550 | Raw | Fruit | 400 | 400 | 400 | mg/100g | Database [DUKE] |
NPO16501 | NPC255550 | Raw | Resin, Exudate, Sap | 63400 | 63400 | 63400 | mg/100g | Database [DUKE] |
NPO16501 | NPC255550 | Raw | Tissue Culture | 0.059 | 0.059 | 0.059 | mg/100g | Database [DUKE] |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT5472 | Individual Protein | Tyrosyl-tRNA synthetase | Homo sapiens | Ki | = | 42000.0 | nM | PMID[467846] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Ki | = | 2000.0 | nM | PMID[467847] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Ki | = | 1800.0 | nM | PMID[467850] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | EC50 | = | 44.8 | nM | PMID[467850] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Ki | = | 1700.0 | nM | PMID[467850] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Response | = | 65.4 | % | PMID[467852] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 19.95 | nM | PMID[467852] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Ki | = | 2000.0 | nM | PMID[467853] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Hill coefficient | = | 2.0 | n.a. | PMID[467853] |
NPT3118 | Cell Line | Cell line | Homo sapiens | ED50 | = | 3.0 | ug | PMID[467854] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 40.0 | nM | PMID[467855] |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 3800.0 | nM | PMID[467856] |
NPT4064 | Individual Protein | Hormone-sensitive lipase | Rattus norvegicus | Inhibition | = | 33.0 | % | PMID[467857] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Ki | = | 1808.0 | nM | PMID[467858] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | EC50 | = | 44.8 | nM | PMID[467858] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 20.0 | nM | PMID[467859] |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | > | 10000.0 | nM | PMID[467859] |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | > | 10000.0 | nM | PMID[467859] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 40.0 | nM | PMID[467861] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 2.512 | nM | PMID[467863] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Emax | = | 97.0 | % | PMID[467863] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Activity | = | 0.01 | uM | PMID[467864] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Ki | = | 6.0 | nM | PMID[467865] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | IC50 | = | 19.0 | nM | PMID[467865] |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 35481.3 | nM | PMID[467867] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PMID[467867] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 15848.9 | nM | PMID[467868] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 17782.8 | nM | PMID[467868] |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 89125.1 | nM | PMID[467868] |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 2818.4 | nM | PMID[467868] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 31622.8 | nM | PMID[467868] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[467867] |
NPT347 | Cell Line | Lymphoblastoid cells | Homo sapiens | Potency | = | 79432.8 | nM | PMID[467867] |
NPT347 | Cell Line | Lymphoblastoid cells | Homo sapiens | Potency | = | 3981.1 | nM | PMID[467867] |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 35481.3 | nM | PMID[467869] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 39810.7 | nM | PMID[467867] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 2511.9 | nM | PMID[467867] |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[467868] |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | n.a. | 756.9 | nM | PMID[467874] |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[467876] |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[467867] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 100000.0 | nM | PMID[467874] |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 1551.0 | nM | PMID[467878] |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | = | 3000.0 | nM | PMID[467878] |
NPT1534 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus | Efficacy | = | 100.0 | % | PMID[467880] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 3.9 | nM | PMID[467880] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Efficacy | = | 78.6 | % | PMID[467880] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Potency | n.a. | 6.5 | nM | PMID[467874] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Potency | n.a. | 32.1 | nM | PMID[467874] |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | n.a. | 9074.3 | nM | PMID[467877] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Potency | n.a. | 91.2 | nM | PMID[467881] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 30637.9 | nM | PMID[467882] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 42163.2 | nM | PMID[467867] |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | n.a. | 8912.5 | nM | PMID[467874] |
NPT103 | Individual Protein | Nuclear receptor ROR-gamma | Homo sapiens | Potency | n.a. | 33491.5 | nM | PMID[467867] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | -6.53 | % | PMID[467883] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 11.4 | % | PMID[467884] |
NPT4515 | Individual Protein | NADH-ubiquinone oxidoreductase chain 1 | Bos taurus | IC50 | = | 52480.75 | nM | PMID[467886] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 8912.5 | nM | PMID[467887] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 29855.4 | nM | PMID[467888] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[467889] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 29855.4 | nM | PMID[467890] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 11220.2 | nM | PMID[467887] |
NPT1885 | Individual Protein | Transient receptor potential cation channel subfamily M member 8 | Mus musculus | IC50 | > | 100000.0 | nM | PMID[467891] |
NPT1885 | Individual Protein | Transient receptor potential cation channel subfamily M member 8 | Mus musculus | IC50 | = | 28000.0 | nM | PMID[467891] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 10870.7 | nM | PMID[467882] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 7943.3 | nM | PMID[467867] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Efficacy | = | 78.6 | % | PMID[467895] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | IC50 | = | 8.0 | nM | PMID[467895] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 5.3 | nM | PMID[467895] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Activity | = | -497.0 | pA/pF | PMID[467896] |
NPT2592 | Individual Protein | Voltage-gated potassium channel subunit Kv1.1 | Homo sapiens | IC50 | = | 29000.0 | nM | PMID[467899] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Ki | = | 1140.0 | nM | PMID[467901] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Ki | = | 2530.0 | nM | PMID[467901] |
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | FC | = | 2.0 | n.a. | PMID[467903] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Ratio | = | 1.885 | n.a. | PMID[467904] |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 49410.0 | nM | PMID[467904] |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | > | 50000.0 | nM | PMID[467904] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 49970.0 | nM | PMID[467904] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 870.0 | nM | PMID[467906] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | FC | = | 1.13 | n.a. | PMID[467906] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | FC | = | 2.81 | n.a. | PMID[467906] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Ratio | = | 6.09 | n.a. | PMID[467906] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 870.96 | nM | PMID[467906] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 1000.0 | nM | PMID[467907] |
NPT2297 | Cell Line | ASPC1 | Homo sapiens | Inhibition | = | 73.0 | % | PMID[467910] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | EC50 | = | 2320.0 | nM | PMID[467911] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Ki | = | 1070.0 | nM | PMID[467912] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 25.9 | nM | PMID[467912] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | Ki | = | 1810.0 | nM | PMID[467912] |
NPT468 | Individual Protein | Vanilloid receptor | Rattus norvegicus | EC50 | = | 44.8 | nM | PMID[467912] |
NPT1535 | Cell Line | U-87 MG | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[467913] |
NPT169 | Cell Line | B16-F10 | Mus musculus | IC50 | > | 100000.0 | nM | PMID[467913] |
NPT1383 | Cell Line | A2058 | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[467913] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 7.2 | nM | PMID[467913] |
NPT570 | Individual Protein | Arachidonate 5-lipoxygenase | Homo sapiens | IC50 | = | 56000.0 | nM | PMID[467915] |
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | EC50 | = | 14020.0 | nM | PMID[467916] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Efficacy | = | 79.0 | % | PMID[467923] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 5.3 | nM | PMID[467923] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | IC50 | = | 8.0 | nM | PMID[467923] |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | IC50 | > | 200000.0 | nM | PMID[467924] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Activity | = | 11.0 | % | PMID[467924] |
NPT439 | Individual Protein | Butyrylcholinesterase | Homo sapiens | Inhibition | = | 20.0 | % | PMID[467924] |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | > | 5600.0 | nM | PMID[467925] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 30200.0 | nM | PMID[467925] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 120000.0 | nM | PMID[467925] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity | = | 281.3 | mm3 | PMID[467925] |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 44.8 | nM | PMID[467927] |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 6001.2 | nM | PubChem BioAssay data set |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 33469.3 | nM | PubChem BioAssay data set |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 47276.7 | nM | PubChem BioAssay data set |
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | n.a. | 15074.3 | nM | PubChem BioAssay data set |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 6740 | nM | PubChem BioAssay data set |
NPT939 | Protein Family | Vanilloid receptor | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467841] |
NPT939 | Protein Family | Vanilloid receptor | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467842] |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 260.0 | nM | PMID[467842] |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 15.0 | umol.kg-1 | PMID[467842] |
NPT939 | Protein Family | Vanilloid receptor | Rattus norvegicus | EC50 | = | 30.0 | nM | PMID[467843] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BP | = | -49.5 | mmHg | PMID[467844] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | DOSE | = | 0.001 | mg.kg-1 | PMID[467844] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467845] |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 260.0 | nM | PMID[467845] |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 15.0 | umol.kg-1 | PMID[467845] |
NPT939 | Protein Family | Vanilloid receptor | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467847] |
NPT939 | Protein Family | Vanilloid receptor | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467848] |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 260.0 | nM | PMID[467848] |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 15.0 | umol.kg-1 | PMID[467848] |
NPT939 | Protein Family | Vanilloid receptor | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467849] |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 10.3 | umol.kg-1 | PMID[467849] |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 962.0 | umol.kg-1 | PMID[467849] |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 5.72 | umol.kg-1 | PMID[467849] |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | Dose | = | 0.018 | uM kg-1 | PMID[467849] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 300.0 | nM | PMID[467851] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.099 | mg/ml | PMID[467860] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 39810.7 | nM | PMID[467866] |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 22387.2 | nM | PMID[467868] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[467869] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 1995.3 | nM | PMID[467866] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 15848.9 | nM | PMID[467868] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 28183.8 | nM | PMID[467867] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 22387.2 | nM | PMID[467870] |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 31622.8 | nM | PMID[467867] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 158489.3 | nM | PMID[467866] |
NPT2 | Others | Unspecified | Potency | = | 12589.3 | nM | PMID[467867] | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | n.a. | 15848.9 | nM | PMID[467867] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 19011.5 | nM | PMID[467877] |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | n.a. | 89125.1 | nM | PMID[467874] |
NPT99 | Individual Protein | Peroxisome proliferator-activated receptor gamma | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[467876] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | DILI positive/negative | = | 0.0 | n.a. | PMID[467879] |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 6.29 | % | PMID[467883] |
NPT5473 | Organism | Diaprepes abbreviatus | Diaprepes abbreviatus | Activity | = | 1.02 | cm2 | PMID[467885] |
NPT5474 | Organism | Schistocerca americana | Schistocerca americana | Activity | = | 1.08 | cm2 | PMID[467885] |
NPT2 | Others | Unspecified | IC50 | = | 16982.44 | nM | PMID[467886] | |
NPT2 | Others | Unspecified | IC50 | = | 134896.29 | nM | PMID[467886] | |
NPT2 | Others | Unspecified | Inhibition | = | 20.0 | % | PMID[467886] | |
NPT610 | Others | Molecular identity unknown | Potency | n.a. | 39810.7 | nM | PMID[467876] | |
NPT610 | Others | Molecular identity unknown | Potency | n.a. | 25118.9 | nM | PMID[467867] | |
NPT2 | Others | Unspecified | Potency | n.a. | 25118.9 | nM | PMID[467887] | |
NPT2 | Others | Unspecified | Potency | n.a. | 39810.7 | nM | PMID[467887] | |
NPT2 | Others | Unspecified | Potency | n.a. | 35481.3 | nM | PMID[467887] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1412.5 | nM | PMID[467889] | |
NPT2709 | Organism | Bacillus subtilis subsp. subtilis str. 168 | Bacillus subtilis subsp. subtilis str. 168 | MIC | = | 63000.0 | nM | PMID[467893] |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Inhibition | < | 20.0 | % | PMID[467894] |
NPT2 | Others | Unspecified | Potency | n.a. | 44668.4 | nM | PMID[467887] | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 40.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 42700.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 433.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 75.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 150.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 25330000.0 | nM | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 104.67 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 570.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 554.67 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 1.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1776.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 121.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 8.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 124.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 6.02 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 145.37 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 2.3 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 59000.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 15.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BASO | = | 0.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 231.67 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 12823.67 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 176.33 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 735.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BASOLE | = | 0.0 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 1.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5550000.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 34.43 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 129700.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 13970.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 92.0 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 23.37 | pg | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 376300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 62.03 | fL | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 1.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 5.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBCNUC | = | 0.0 | /100WBC | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1334000.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 50.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 41000.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 314.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 93.67 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 183.3 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 24330000.0 | nM | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 107.67 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 680.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 629.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 2.1 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1530.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 471.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 8.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 126.3 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 5.84 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 145.1 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 2.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 62000.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 17.3 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 118.67 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 14371.67 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 374.33 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 1135.33 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 0.67 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5310000.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 33.03 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 125300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 16000.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 89.67 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 23.6 | pg | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 379300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 62.17 | fL | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 2.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 7.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1256670.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 44.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 43300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 316.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 71.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 173.3 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 27670000.0 | nM | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 103.5 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 756.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 217.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 2.2 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1416.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 119.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 8.5 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 116.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 5.75 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 147.2 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 2.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 61300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 11.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 0.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 7477.33 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 60.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 496.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 0.0 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5280000.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 33.53 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 127000.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 8030.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 92.67 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 24.13 | pg | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 379000.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 63.63 | fL | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 1.0 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 6.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBCNUC | = | 0.33 | /100WBC | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1342330.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 52.67 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 40700.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 391.0 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 83.67 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 180.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 25670000.0 | nM | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 105.33 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 620.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 166.33 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1770.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 115.67 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 8.67 | U.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 131.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 6.01 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 146.17 | mEq.L-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 1.7 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 60300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 18.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 117.33 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 12147.67 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 58.67 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 1243.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 1.0 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5710000.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 34.97 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 133300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 13570.0 | cells.uL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 88.67 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 23.4 | pg | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 381300.0 | ug.mL-1 | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 61.27 | fL | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 0.33 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 10.0 | % | PMID[467897] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1274000.0 | cells.uL-1 | PMID[467897] |
NPT713 | Individual Protein | Bile salt export pump | Homo sapiens | IC50 | < | 10000.0 | nM | PMID[467900] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LD50 | = | 161.2 | mg.kg-1 | PMID[467904] |
NPT21750 | LIPID | Lipid bilayer | n.a. | Activity | = | 18.0 | uM | PMID[467905] |
NPT27 | Others | Unspecified | Stability | = | 100.0 | % | PMID[467907] | |
NPT27 | Others | Unspecified | Stability | = | 96.0 | % | PMID[467907] | |
NPT27 | Others | Unspecified | Stability | = | 99.3 | % | PMID[467907] | |
NPT27 | Others | Unspecified | Stability | = | 99.0 | % | PMID[467907] | |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 1.12 | % | PMID[467908] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Hit score | = | 0.1538 | n.a. | PMID[467909] |
NPT27 | Others | Unspecified | LD50 | = | 7.5 | mg.kg-1 | PMID[467912] | |
NPT27 | Others | Unspecified | LD50 | = | 118.8 | mg.kg-1 | PMID[467912] | |
NPT24765 | CELL-LINE | SK-MEL-25 | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[467913] |
NPT2 | Others | Unspecified | IC50 | > | 100000.0 | nM | PMID[467913] | |
NPT2 | Others | Unspecified | EC50 | = | 16370.0 | nM | PMID[467916] | |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 26.63 | % | PMID[467917] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.12 | % | PMID[467918] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[467920] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[467920] |
NPT21750 | LIPID | Lipid bilayer | n.a. | deltaG | = | -0.5 | kcal/mol | PMID[467921] |
NPT21750 | LIPID | Lipid bilayer | n.a. | deltaG | = | -0.6 | kcal/mol | PMID[467921] |
NPT35 | Others | n.a. | IC50 | = | 50300.0 | nM | PMID[467924] | |
NPT27 | Others | Unspecified | permeability | = | 10.3 | 10^-6 cm/s | PMID[467924] | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 50.0 | ug.mL-1 | PMID[467926] |
NPT2 | Others | Unspecified | Potency | n.a. | 33491.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 47276.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 60011.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 21293 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 29849.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 16774.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 15074.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 23710.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 18821.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 53045.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 3346.9 | nM | PubChem BioAssay data set |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC255550 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC308885 |
0.9762 | High Similarity | NPC218530 |
0.976 | High Similarity | NPC130595 |
0.976 | High Similarity | NPC93882 |
0.9683 | High Similarity | NPC285078 |
0.9683 | High Similarity | NPC6854 |
0.9683 | High Similarity | NPC313737 |
0.9286 | High Similarity | NPC153990 |
0.907 | High Similarity | NPC114102 |
0.9062 | High Similarity | NPC155838 |
0.9 | High Similarity | NPC214869 |
0.8992 | High Similarity | NPC52029 |
0.8992 | High Similarity | NPC35961 |
0.8992 | High Similarity | NPC195749 |
0.8837 | High Similarity | NPC186898 |
0.8837 | High Similarity | NPC251571 |
0.876 | High Similarity | NPC301713 |
0.8651 | High Similarity | NPC53596 |
0.8651 | High Similarity | NPC289330 |
0.8651 | High Similarity | NPC17388 |
0.8651 | High Similarity | NPC160120 |
0.8651 | High Similarity | NPC471308 |
0.8601 | High Similarity | NPC275027 |
0.8529 | High Similarity | NPC204848 |
0.8529 | High Similarity | NPC312770 |
0.8529 | High Similarity | NPC41473 |
0.8529 | High Similarity | NPC14600 |
0.8529 | High Similarity | NPC160607 |
0.8527 | High Similarity | NPC13020 |
0.8527 | High Similarity | NPC140359 |
0.8473 | Intermediate Similarity | NPC251466 |
0.8467 | Intermediate Similarity | NPC299583 |
0.8467 | Intermediate Similarity | NPC296898 |
0.845 | Intermediate Similarity | NPC471315 |
0.845 | Intermediate Similarity | NPC471314 |
0.8409 | Intermediate Similarity | NPC191302 |
0.8397 | Intermediate Similarity | NPC246133 |
0.8397 | Intermediate Similarity | NPC170583 |
0.8397 | Intermediate Similarity | NPC71105 |
0.8397 | Intermediate Similarity | NPC152186 |
0.8397 | Intermediate Similarity | NPC182147 |
0.8397 | Intermediate Similarity | NPC207541 |
0.8333 | Intermediate Similarity | NPC156944 |
0.8321 | Intermediate Similarity | NPC131204 |
0.8321 | Intermediate Similarity | NPC301050 |
0.8321 | Intermediate Similarity | NPC300955 |
0.832 | Intermediate Similarity | NPC142599 |
0.8286 | Intermediate Similarity | NPC100478 |
0.8286 | Intermediate Similarity | NPC222039 |
0.8276 | Intermediate Similarity | NPC52475 |
0.8271 | Intermediate Similarity | NPC291449 |
0.8271 | Intermediate Similarity | NPC41331 |
0.8271 | Intermediate Similarity | NPC157740 |
0.8271 | Intermediate Similarity | NPC172403 |
0.8271 | Intermediate Similarity | NPC99798 |
0.8239 | Intermediate Similarity | NPC5462 |
0.8219 | Intermediate Similarity | NPC18614 |
0.8211 | Intermediate Similarity | NPC246358 |
0.8211 | Intermediate Similarity | NPC7097 |
0.8211 | Intermediate Similarity | NPC233731 |
0.8211 | Intermediate Similarity | NPC36108 |
0.8209 | Intermediate Similarity | NPC246974 |
0.8209 | Intermediate Similarity | NPC147247 |
0.8148 | Intermediate Similarity | NPC470706 |
0.814 | Intermediate Similarity | NPC268572 |
0.8125 | Intermediate Similarity | NPC321505 |
0.8125 | Intermediate Similarity | NPC283468 |
0.8125 | Intermediate Similarity | NPC115144 |
0.8125 | Intermediate Similarity | NPC277857 |
0.8125 | Intermediate Similarity | NPC179825 |
0.8125 | Intermediate Similarity | NPC191376 |
0.8088 | Intermediate Similarity | NPC329595 |
0.8088 | Intermediate Similarity | NPC326599 |
0.808 | Intermediate Similarity | NPC156840 |
0.808 | Intermediate Similarity | NPC8547 |
0.808 | Intermediate Similarity | NPC166837 |
0.808 | Intermediate Similarity | NPC78918 |
0.808 | Intermediate Similarity | NPC173746 |
0.808 | Intermediate Similarity | NPC257124 |
0.808 | Intermediate Similarity | NPC139617 |
0.8074 | Intermediate Similarity | NPC469977 |
0.8069 | Intermediate Similarity | NPC147390 |
0.8069 | Intermediate Similarity | NPC246587 |
0.8069 | Intermediate Similarity | NPC428 |
0.8069 | Intermediate Similarity | NPC135538 |
0.8069 | Intermediate Similarity | NPC476571 |
0.8069 | Intermediate Similarity | NPC24233 |
0.8067 | Intermediate Similarity | NPC329837 |
0.8062 | Intermediate Similarity | NPC122009 |
0.8014 | Intermediate Similarity | NPC103379 |
0.8014 | Intermediate Similarity | NPC477565 |
0.8014 | Intermediate Similarity | NPC477838 |
0.8014 | Intermediate Similarity | NPC477837 |
0.8 | Intermediate Similarity | NPC310338 |
0.8 | Intermediate Similarity | NPC43275 |
0.8 | Intermediate Similarity | NPC281298 |
0.7986 | Intermediate Similarity | NPC185838 |
0.7984 | Intermediate Similarity | NPC164386 |
0.7984 | Intermediate Similarity | NPC120075 |
0.7945 | Intermediate Similarity | NPC470935 |
0.7945 | Intermediate Similarity | NPC153644 |
0.7945 | Intermediate Similarity | NPC471032 |
0.7943 | Intermediate Similarity | NPC231572 |
0.7939 | Intermediate Similarity | NPC165133 |
0.7939 | Intermediate Similarity | NPC242885 |
0.7939 | Intermediate Similarity | NPC232316 |
0.7939 | Intermediate Similarity | NPC227217 |
0.7939 | Intermediate Similarity | NPC117780 |
0.7939 | Intermediate Similarity | NPC56214 |
0.7939 | Intermediate Similarity | NPC95614 |
0.7923 | Intermediate Similarity | NPC470626 |
0.7917 | Intermediate Similarity | NPC294249 |
0.7914 | Intermediate Similarity | NPC473463 |
0.7905 | Intermediate Similarity | NPC277669 |
0.7905 | Intermediate Similarity | NPC127402 |
0.7905 | Intermediate Similarity | NPC76213 |
0.7895 | Intermediate Similarity | NPC298486 |
0.7883 | Intermediate Similarity | NPC160193 |
0.7879 | Intermediate Similarity | NPC183262 |
0.7879 | Intermediate Similarity | NPC83279 |
0.7877 | Intermediate Similarity | NPC476151 |
0.7872 | Intermediate Similarity | NPC254610 |
0.7872 | Intermediate Similarity | NPC193528 |
0.7863 | Intermediate Similarity | NPC311595 |
0.7863 | Intermediate Similarity | NPC24474 |
0.7852 | Intermediate Similarity | NPC133011 |
0.7852 | Intermediate Similarity | NPC82285 |
0.7846 | Intermediate Similarity | NPC293619 |
0.7838 | Intermediate Similarity | NPC220858 |
0.7838 | Intermediate Similarity | NPC97221 |
0.7838 | Intermediate Similarity | NPC151895 |
0.7838 | Intermediate Similarity | NPC192768 |
0.7838 | Intermediate Similarity | NPC88249 |
0.7823 | Intermediate Similarity | NPC231705 |
0.7821 | Intermediate Similarity | NPC66573 |
0.782 | Intermediate Similarity | NPC38996 |
0.782 | Intermediate Similarity | NPC160380 |
0.7803 | Intermediate Similarity | NPC263835 |
0.78 | Intermediate Similarity | NPC477564 |
0.78 | Intermediate Similarity | NPC2295 |
0.7795 | Intermediate Similarity | NPC195873 |
0.7786 | Intermediate Similarity | NPC284855 |
0.7786 | Intermediate Similarity | NPC282477 |
0.777 | Intermediate Similarity | NPC207824 |
0.777 | Intermediate Similarity | NPC60538 |
0.7769 | Intermediate Similarity | NPC221049 |
0.7761 | Intermediate Similarity | NPC85488 |
0.776 | Intermediate Similarity | NPC227894 |
0.7748 | Intermediate Similarity | NPC295691 |
0.7748 | Intermediate Similarity | NPC2413 |
0.7748 | Intermediate Similarity | NPC127674 |
0.7748 | Intermediate Similarity | NPC189266 |
0.7748 | Intermediate Similarity | NPC184026 |
0.7748 | Intermediate Similarity | NPC5238 |
0.7748 | Intermediate Similarity | NPC204828 |
0.7748 | Intermediate Similarity | NPC193949 |
0.7748 | Intermediate Similarity | NPC249797 |
0.7748 | Intermediate Similarity | NPC278799 |
0.7748 | Intermediate Similarity | NPC39701 |
0.7748 | Intermediate Similarity | NPC110416 |
0.7748 | Intermediate Similarity | NPC107602 |
0.7748 | Intermediate Similarity | NPC207757 |
0.7748 | Intermediate Similarity | NPC276588 |
0.7748 | Intermediate Similarity | NPC54379 |
0.7748 | Intermediate Similarity | NPC172765 |
0.7748 | Intermediate Similarity | NPC469817 |
0.7744 | Intermediate Similarity | NPC269843 |
0.7744 | Intermediate Similarity | NPC60962 |
0.7744 | Intermediate Similarity | NPC158949 |
0.7744 | Intermediate Similarity | NPC14007 |
0.7744 | Intermediate Similarity | NPC224814 |
0.7744 | Intermediate Similarity | NPC207613 |
0.7744 | Intermediate Similarity | NPC189844 |
0.7744 | Intermediate Similarity | NPC109083 |
0.7734 | Intermediate Similarity | NPC165646 |
0.7717 | Intermediate Similarity | NPC137685 |
0.7717 | Intermediate Similarity | NPC474149 |
0.771 | Intermediate Similarity | NPC259638 |
0.771 | Intermediate Similarity | NPC86947 |
0.771 | Intermediate Similarity | NPC39793 |
0.7708 | Intermediate Similarity | NPC275150 |
0.7704 | Intermediate Similarity | NPC280704 |
0.7704 | Intermediate Similarity | NPC317769 |
0.7704 | Intermediate Similarity | NPC31344 |
0.7698 | Intermediate Similarity | NPC476570 |
0.7697 | Intermediate Similarity | NPC147091 |
0.7692 | Intermediate Similarity | NPC303370 |
0.7687 | Intermediate Similarity | NPC324571 |
0.7687 | Intermediate Similarity | NPC343720 |
0.7687 | Intermediate Similarity | NPC54872 |
0.7687 | Intermediate Similarity | NPC211992 |
0.7687 | Intermediate Similarity | NPC476343 |
0.7687 | Intermediate Similarity | NPC70752 |
0.7687 | Intermediate Similarity | NPC262156 |
0.7687 | Intermediate Similarity | NPC473853 |
0.7687 | Intermediate Similarity | NPC312675 |
0.7687 | Intermediate Similarity | NPC184651 |
0.7687 | Intermediate Similarity | NPC201777 |
0.7687 | Intermediate Similarity | NPC113865 |
0.7687 | Intermediate Similarity | NPC470212 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC255550 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD3145 | Approved |
1.0 | High Similarity | NPD3144 | Approved |
0.976 | High Similarity | NPD2674 | Phase 3 |
0.8613 | High Similarity | NPD7153 | Discontinued |
0.8467 | Intermediate Similarity | NPD2161 | Phase 2 |
0.8125 | Intermediate Similarity | NPD4123 | Phase 3 |
0.8099 | Intermediate Similarity | NPD6331 | Phase 2 |
0.808 | Intermediate Similarity | NPD228 | Approved |
0.803 | Intermediate Similarity | NPD2337 | Clinical (unspecified phase) |
0.797 | Intermediate Similarity | NPD3676 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD4675 | Approved |
0.7852 | Intermediate Similarity | NPD4678 | Approved |
0.7785 | Intermediate Similarity | NPD824 | Approved |
0.7755 | Intermediate Similarity | NPD4739 | Approved |
0.7704 | Intermediate Similarity | NPD1669 | Approved |
0.7703 | Intermediate Similarity | NPD7526 | Approved |
0.7703 | Intermediate Similarity | NPD52 | Approved |
0.7703 | Intermediate Similarity | NPD7527 | Clinical (unspecified phase) |
0.7681 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7655 | Intermediate Similarity | NPD3060 | Approved |
0.7647 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7639 | Intermediate Similarity | NPD3656 | Approved |
0.7603 | Intermediate Similarity | NPD6658 | Clinical (unspecified phase) |
0.7597 | Intermediate Similarity | NPD9377 | Approved |
0.7597 | Intermediate Similarity | NPD9379 | Approved |
0.7586 | Intermediate Similarity | NPD4664 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7571 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7564 | Intermediate Similarity | NPD7201 | Clinical (unspecified phase) |
0.7537 | Intermediate Similarity | NPD2667 | Approved |
0.7537 | Intermediate Similarity | NPD2668 | Approved |
0.7532 | Intermediate Similarity | NPD4083 | Discontinued |
0.7518 | Intermediate Similarity | NPD839 | Approved |
0.7518 | Intermediate Similarity | NPD840 | Approved |
0.7517 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD1375 | Discontinued |
0.75 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD2157 | Approved |
0.7482 | Intermediate Similarity | NPD1712 | Approved |
0.7468 | Intermediate Similarity | NPD5772 | Approved |
0.7468 | Intermediate Similarity | NPD5773 | Approved |
0.7467 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.7465 | Intermediate Similarity | NPD1558 | Phase 1 |
0.745 | Intermediate Similarity | NPD4357 | Discontinued |
0.7436 | Intermediate Similarity | NPD7833 | Phase 2 |
0.7436 | Intermediate Similarity | NPD7832 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD4055 | Discovery |
0.7436 | Intermediate Similarity | NPD5604 | Discontinued |
0.7436 | Intermediate Similarity | NPD7831 | Phase 2 |
0.7432 | Intermediate Similarity | NPD5241 | Discontinued |
0.7431 | Intermediate Similarity | NPD6895 | Approved |
0.7431 | Intermediate Similarity | NPD6896 | Approved |
0.7417 | Intermediate Similarity | NPD2122 | Discontinued |
0.7415 | Intermediate Similarity | NPD4162 | Approved |
0.7415 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7405 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7394 | Intermediate Similarity | NPD7477 | Discontinued |
0.7372 | Intermediate Similarity | NPD2230 | Approved |
0.7372 | Intermediate Similarity | NPD2232 | Approved |
0.7372 | Intermediate Similarity | NPD2233 | Approved |
0.7361 | Intermediate Similarity | NPD2653 | Approved |
0.7338 | Intermediate Similarity | NPD3055 | Approved |
0.7338 | Intermediate Similarity | NPD3053 | Approved |
0.7338 | Intermediate Similarity | NPD4772 | Phase 2 |
0.7338 | Intermediate Similarity | NPD4773 | Phase 2 |
0.7333 | Intermediate Similarity | NPD1357 | Approved |
0.7328 | Intermediate Similarity | NPD821 | Approved |
0.7325 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD5109 | Approved |
0.7324 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7324 | Intermediate Similarity | NPD5110 | Phase 2 |
0.732 | Intermediate Similarity | NPD4005 | Discontinued |
0.7315 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7308 | Intermediate Similarity | NPD2560 | Approved |
0.7308 | Intermediate Similarity | NPD2563 | Approved |
0.7285 | Intermediate Similarity | NPD4584 | Approved |
0.7279 | Intermediate Similarity | NPD9384 | Approved |
0.7279 | Intermediate Similarity | NPD9381 | Approved |
0.7273 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD1726 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD2898 | Approved |
0.7266 | Intermediate Similarity | NPD5311 | Approved |
0.7266 | Intermediate Similarity | NPD5310 | Approved |
0.726 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD3693 | Clinical (unspecified phase) |
0.7254 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7254 | Intermediate Similarity | NPD1024 | Discontinued |
0.725 | Intermediate Similarity | NPD4606 | Clinical (unspecified phase) |
0.725 | Intermediate Similarity | NPD4010 | Discontinued |
0.7244 | Intermediate Similarity | NPD6818 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD2977 | Approved |
0.7244 | Intermediate Similarity | NPD2978 | Approved |
0.723 | Intermediate Similarity | NPD1044 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD5602 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD7261 | Clinical (unspecified phase) |
0.7194 | Intermediate Similarity | NPD9622 | Approved |
0.719 | Intermediate Similarity | NPD6031 | Approved |
0.719 | Intermediate Similarity | NPD3640 | Phase 3 |
0.719 | Intermediate Similarity | NPD6030 | Approved |
0.719 | Intermediate Similarity | NPD3641 | Approved |
0.719 | Intermediate Similarity | NPD3639 | Approved |
0.7181 | Intermediate Similarity | NPD2460 | Phase 3 |
0.7181 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7181 | Intermediate Similarity | NPD4237 | Approved |
0.7181 | Intermediate Similarity | NPD2458 | Approved |
0.7181 | Intermediate Similarity | NPD2459 | Approved |
0.7179 | Intermediate Similarity | NPD5720 | Discontinued |
0.7171 | Intermediate Similarity | NPD1771 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD1424 | Approved |
0.7163 | Intermediate Similarity | NPD9620 | Approved |
0.7163 | Intermediate Similarity | NPD9619 | Approved |
0.7163 | Intermediate Similarity | NPD9621 | Approved |
0.7163 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7154 | Intermediate Similarity | NPD9296 | Approved |
0.7143 | Intermediate Similarity | NPD3686 | Approved |
0.7143 | Intermediate Similarity | NPD3687 | Approved |
0.7143 | Intermediate Similarity | NPD4108 | Discontinued |
0.7143 | Intermediate Similarity | NPD9634 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD4186 | Clinical (unspecified phase) |
0.7123 | Intermediate Similarity | NPD2492 | Phase 1 |
0.7122 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7122 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7115 | Intermediate Similarity | NPD5090 | Approved |
0.7115 | Intermediate Similarity | NPD5089 | Approved |
0.7114 | Intermediate Similarity | NPD3655 | Clinical (unspecified phase) |
0.7113 | Intermediate Similarity | NPD2040 | Clinical (unspecified phase) |
0.7113 | Intermediate Similarity | NPD9494 | Approved |
0.7103 | Intermediate Similarity | NPD5837 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7103 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7099 | Intermediate Similarity | NPD3022 | Approved |
0.7099 | Intermediate Similarity | NPD3021 | Approved |
0.7097 | Intermediate Similarity | NPD4017 | Approved |
0.7095 | Intermediate Similarity | NPD3156 | Discontinued |
0.7086 | Intermediate Similarity | NPD3692 | Discontinued |
0.7086 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD302 | Approved |
0.7083 | Intermediate Similarity | NPD597 | Approved |
0.7083 | Intermediate Similarity | NPD601 | Approved |
0.7083 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD598 | Approved |
0.7081 | Intermediate Similarity | NPD2821 | Approved |
0.7075 | Intermediate Similarity | NPD6111 | Discontinued |
0.7071 | Intermediate Similarity | NPD3685 | Discontinued |
0.7071 | Intermediate Similarity | NPD1420 | Approved |
0.7071 | Intermediate Similarity | NPD1421 | Approved |
0.7071 | Intermediate Similarity | NPD4129 | Approved |
0.707 | Intermediate Similarity | NPD7945 | Clinical (unspecified phase) |
0.7066 | Intermediate Similarity | NPD7132 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD596 | Approved |
0.7063 | Intermediate Similarity | NPD600 | Approved |
0.7059 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7055 | Intermediate Similarity | NPD27 | Approved |
0.7055 | Intermediate Similarity | NPD2489 | Approved |
0.7051 | Intermediate Similarity | NPD5617 | Suspended |
0.7047 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.7039 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7037 | Intermediate Similarity | NPD6071 | Discontinued |
0.7034 | Intermediate Similarity | NPD1132 | Approved |
0.7034 | Intermediate Similarity | NPD1423 | Approved |
0.7034 | Intermediate Similarity | NPD1130 | Approved |
0.7034 | Intermediate Similarity | NPD1136 | Approved |
0.7032 | Intermediate Similarity | NPD2883 | Discontinued |
0.7032 | Intermediate Similarity | NPD5267 | Discontinued |
0.7025 | Intermediate Similarity | NPD5563 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD2684 | Approved |
0.7018 | Intermediate Similarity | NPD6377 | Clinical (unspecified phase) |
0.7015 | Intermediate Similarity | NPD2234 | Approved |
0.7015 | Intermediate Similarity | NPD2228 | Approved |
0.7015 | Intermediate Similarity | NPD2229 | Approved |
0.7007 | Intermediate Similarity | NPD1772 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD1444 | Approved |
0.7 | Intermediate Similarity | NPD1445 | Approved |
0.6987 | Remote Similarity | NPD3111 | Phase 1 |
0.6986 | Remote Similarity | NPD3059 | Approved |
0.6986 | Remote Similarity | NPD3062 | Approved |
0.6986 | Remote Similarity | NPD3061 | Approved |
0.698 | Remote Similarity | NPD1632 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD5084 | Clinical (unspecified phase) |
0.6972 | Remote Similarity | NPD3568 | Approved |
0.6972 | Remote Similarity | NPD3567 | Approved |
0.6966 | Remote Similarity | NPD1039 | Discontinued |
0.6962 | Remote Similarity | NPD7298 | Approved |
0.6957 | Remote Similarity | NPD2594 | Approved |
0.6957 | Remote Similarity | NPD2595 | Approved |
0.6954 | Remote Similarity | NPD44 | Approved |
0.6954 | Remote Similarity | NPD6364 | Approved |
0.6951 | Remote Similarity | NPD677 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD6583 | Phase 3 |
0.695 | Remote Similarity | NPD6582 | Phase 2 |
0.6943 | Remote Similarity | NPD3296 | Phase 1 |
0.6943 | Remote Similarity | NPD6502 | Phase 2 |
0.6929 | Remote Similarity | NPD776 | Approved |
0.6928 | Remote Similarity | NPD6783 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD950 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD259 | Phase 1 |
0.6913 | Remote Similarity | NPD6380 | Phase 1 |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.